KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Sep 17, 2021 $133.77 $137.96 $131.20 $137.60 425 065
Sep 16, 2021 $134.22 $134.70 $130.07 $133.77 147 149
Sep 15, 2021 $131.87 $136.50 $131.62 $134.16 305 832
Sep 14, 2021 $132.54 $133.75 $131.50 $132.19 99 057
Sep 13, 2021 $133.23 $134.59 $132.39 $132.58 114 581
Sep 10, 2021 $131.73 $133.06 $129.35 $132.43 148 168
Sep 09, 2021 $130.00 $131.90 $128.91 $130.97 128 520
Sep 08, 2021 $129.55 $129.93 $127.42 $129.51 117 799
Sep 07, 2021 $130.81 $131.56 $128.89 $129.36 87 840
Sep 03, 2021 $132.06 $133.49 $130.54 $131.32 120 813
Sep 02, 2021 $130.70 $131.89 $128.87 $131.82 309 139
Sep 01, 2021 $133.88 $135.69 $129.28 $129.70 430 236
Aug 31, 2021 $133.20 $135.49 $133.20 $133.88 322 632
Aug 30, 2021 $129.97 $132.95 $129.97 $132.76 201 766
Aug 27, 2021 $126.82 $130.45 $126.49 $129.52 148 588
Aug 26, 2021 $127.47 $130.11 $127.16 $127.16 213 992
Aug 25, 2021 $125.24 $127.91 $123.87 $127.08 156 173
Aug 24, 2021 $125.28 $125.28 $120.39 $125.24 143 316
Aug 23, 2021 $123.67 $125.72 $122.60 $125.13 347 142
Aug 20, 2021 $120.43 $122.57 $120.20 $122.14 187 683
Aug 19, 2021 $123.76 $125.41 $119.31 $119.99 224 815
Aug 18, 2021 $125.38 $126.31 $124.06 $124.61 150 659
Aug 17, 2021 $121.13 $125.06 $121.13 $124.81 257 939
Aug 16, 2021 $122.00 $123.22 $120.31 $122.22 129 709
Aug 13, 2021 $123.45 $124.35 $122.41 $122.67 60 006
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT